The combination of incorrect and overly frequent application of antibiotics and insufficient hygiene measures in hospitals leads to a worldwide rise in the number of resistant germs for which ever less effective therapies exist. The scientists of the "Biogenic Nano-Therapeutics" group develop intelligent mechanisms of action and nano-systems that transport known antibiotics specifically to infected sites in the human body. In their work, they use modern biomimetic systems that utilise mechanisms found in nature or are derived from them. This allows for an effective control of pathogenic bacteria with minimal adverse effects. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
- Biogenic nano therapy for bacterial infections – extracellular vesicles as novel carriers for antibiotics, NanoMatFutur programme from the Federal Ministry for Research and Education (BMBF) : BEVA
A current overview of the team and further information about the research group can be found on the HIPS page.